Having trouble viewing email? View in web browser

The C-View software option for Selenia Dimensions tomosynthesis systems streamlines 3D (breast tomosynthesis) exams by using 3D data to generate 2D images, thus eliminating the 2D exposure. A 3D exam with C-View software offers a number of advantages including:

Improved Patient Care

  A patient dose similar to a 2D only exam.1
  With a faster scan time - less than 4 seconds per view – there is less compression time for patient,2 improving patient comfort and lowering risk of movement.
Improved Outcomes

  Superior clinical performance compared to 2D alone.1
  Increased diagnostic accuracy and reduced false-positive recall rates compared to 2D alone.1
The addition of the C-View software adds to the growing portfolio of Hologic 3D mammography options, each designed for improved performance and optimal workflow. With no additional add-ons, the software offers a simple user interface allowing you to easily add 3D procedures as needed.

Hologic 3D provides a superior mammogram.3
Hologic 3D screening finds invasive cancer 40% earlier than 2D alone4-6while also reducing false-positive recalls by up to 40%.6-7

The Affirm tomosynthesis biopsy procedure targets areas only found with 3D imaging while also offering faster procedures and lower dose compared to stereotactic biopsy.

Eviva breast biopsy device for minimally invasive breast biopsy.

Trident Specimen Radiography system allows rapid verification of your core biopsy samples.

3D Mammography Resources:
  Using tomosynthesis in clinical practice
  Incorporating tomosynthesis into your practice
  Hologic You Tube Site
  ACR coding guidance for performance of breast tomosynthesis studies using C-View software

LEARN MORE: Email tomoinfo@hologic.com or contact your Hologic representative.
1 FDA PMA submission P080003/S001
2  Compared to combo mode (tomosynthesis + digital mammography)
3. Rafferty E, Park J, Philpotts L, et al. “Assessing Radiologist Performance Using Combined Digital Mammography and Breast Tomosynthesis Compared with Digital Mammography Alone: Results of a Multicenter, Multireader Trial.” Radiology. 2013 Jan; 266(1):104-13. Epub 2012 Nov 20.
4 Skaane P, Bandos A, Gullien R, et al. “Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening Program.” Radiology. 2013 Apr; 267(1):47-56. Epub 2013 Jan 7.
5 Ciatto S, Houssami N, Bernardi D, et al. “Integration of 3D Digital Mammography with Tomosynthesis for Population Breast-Cancer Screening (STORM): A Prospective Comparison Study” The Lancet Oncology. Epub 2013 Apr 25.
6 Rose S, Tidwell A, Bujnock L, et al. “Implementation of Breast Tomosynthesis in a Routine Screening Practice: An Observational Study.” American Journal of Roentengenology. 2013 Jun; 200(6): 1401-1408. Epub 2013 May 22.
7 Haas B, Philpotts L, Kalra et al. “Comparison of Tomosynthesis Plus Digital Mammography and Digital Mammography Alone for Breast Cancer Screening.” Radiology. 2013 Jul. [Epub ahead of print]

Hologic, Affirm,C-View, Dimensions, Eviva, Selenia and Trident are trademarks and/or registered trademarks of Hologic and/or its subsidiaries in the U.S. and/or other countries. This information is intended for medical professionals in the U.S. and other markets and is not intended as a product solicitation or promotion where such activities are prohibited. Because Hologic materials are distributed through websites, eBroadcasts and tradeshows, it is not always possible to control where such materials appear. For specific information on what products are available for sale in a particular country, write to womenshealth@hologic.com.